Inpatient pharmacy product with declining sales
The positive results from the initial phase of the program encouraged the client to extend the program through the end of the year. The consistent growth through the end of the year earned an additional 1-year extension for the program, which has shown a dramatic increase in sales through the first 9 months. Additionally, the client has seen the impact of the program beyond the orders taken, as territories receiving tele-sales coverage from PharmaKinnex outperformed those that did not. This then resulted in another 1-year extension for the program.